{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:44:46Z","timestamp":1760424286333},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1006\/exnr.1998.6873","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T23:00:46Z","timestamp":1033945246000},"page":"49-58","source":"Crossref","is-referenced-by-count":12,"title":["Onset and Progression of Motor Deficits in Motor Neuron Degeneration (mnd) Mice Are Unaltered by the Glycine\/NMDA Receptor Antagonist L-701,324 or the MAO-B Inhibitorr(\u2212)-Deprenyl"],"prefix":"10.1006","volume":"155","author":[{"given":"S.","family":"Boyce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.M.J.","family":"Rupniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.G.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1998.6873_RF1","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1212\/WNL.46.5.1244","volume":"46","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6873_RF2","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.13-09-04042.1993","article-title":"Rescue of axotomised immature rat facial motorneurons by R(\u2212)-deprenyl: Stereospecificity and independence from monoamine oxidase inhibition","volume":"13","author":"Ansari","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1998.6873_RF3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.56.2.197","article-title":"A pilot trial of dextromethorphan in amyotrophic lateral sclerosis","volume":"56","author":"Askmark","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1006\/exnr.1998.6873_RF4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01245357","article-title":"Increased binding of3","volume":"89","author":"Aquilonius","year":"1992","journal-title":"J. Neural. Transm. Genet. Sect."},{"key":"10.1006\/exnr.1998.6873_RF5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1471-4159.1993.tb03323.x","article-title":"Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neurone disease","volume":"60","author":"Battaglioli","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.6873_RF6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole study group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1998.6873_RF7","first-page":"492","article-title":"Anti-convulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex","volume":"279","author":"Bristow","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.1998.6873_RF8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.410330408","article-title":"Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)","volume":"33","author":"Bronson","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005072-199107000-00009","article-title":"Neurofilament distribution is altered in theMnd","volume":"50","author":"Callahan","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF10","first-page":"1443","article-title":"Systemic administration of rhIGF-1 enhanced regeneration after sciatic nerve crush injury in mice","volume":"274","author":"Contreras","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.1998.6873_RF11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(93)92615-Z","article-title":"Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA\/kainate receptors","volume":"314","author":"Couratier","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/exnr.1998.6873_RF12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp.31.6.535","article-title":"An hereditary motor neurone disease with progressive denervation of muscle in the mouse; the mutant \u2018wobbler.\u2019","volume":"31","author":"Duchen","year":"1968","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1006\/exnr.1998.6873_RF13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0306-4522(89)90030-4","article-title":"Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity\u2014Effects of the monosialoganglioside GMI","volume":"31","author":"Elliott","year":"1989","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6873_RF14","first-page":"S304","article-title":"Neuroprotective effects of the glycine site antagonist (+)cis-4-methyl-HA-966 (L-687,414) in rat focal ischaemia model","volume":"11","author":"Gill","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1006\/exnr.1998.6873_RF15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of Vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclersis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0022-510X(95)00081-C","article-title":"Beneficial effects of insulin-like growth factor-I on wobbler mouse motorneuron disease","volume":"129","author":"Hantai","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/exnr.1998.6873_RF17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1476-5381.1993.tb13768.x","article-title":"Lack of effect of L-687,414 ((+)cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology","volume":"110","author":"Hargreaves","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6873_RF18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(92)90201-E","article-title":"The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model","volume":"216","author":"Hatfield","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6873_RF19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0404.1991.tb05020.x","article-title":"A review of the pharmacology of selegiline","volume":"84","author":"Heinonen","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1006\/exnr.1998.6873_RF20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.39.7.956","article-title":"Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease","volume":"39","author":"Hugon","year":"1989","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6873_RF21","first-page":"322P","article-title":"L-701,324, a glycine\/NMDA receptor antagonist, attenuates activation of the mesolimbic dopamine system by phencyclidine","volume":"114","author":"Hutson","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6873_RF22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410370413","article-title":"Effects of brain-derived neurotrophic factor in wobbler mouse motor neuron disease","volume":"37","author":"Ikeda","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1017\/S0317167100041652","article-title":"Excitatory amino acid receptor antagonist in murine motorneurone disease (Wobbler mouse)","volume":"19","author":"Krieger","year":"1992","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1006\/exnr.1998.6873_RF24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1006\/exnr.1998.6873_RF25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-1 on progression of ALS: A placebo-controlled study","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6873_RF26","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1212\/WNL.47.6_Suppl_4.228S","article-title":"Animal models of motor neuron diseases: Research directions","volume":"47","author":"Ludolph","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6873_RF27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00863772","article-title":"An open-randomised clinical trial of selegiline in amyotrophic lateral sclerosis","volume":"241","author":"Mazzini","year":"1994","journal-title":"J. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/01677068609106858","article-title":"Autosomal dominance in a late-onset motor neuron disease in the mouse","volume":"3","author":"Messer","year":"1986","journal-title":"J. Neurogen."},{"key":"10.1006\/exnr.1998.6873_RF29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/01677068709102341","article-title":"Histopathology of the late-onset motor degeneration (Mnd) mutant in the mouse","volume":"4","author":"Messer","year":"1987","journal-title":"J. Neurogenet."},{"key":"10.1006\/exnr.1998.6873_RF30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.410390215","article-title":"A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in lateral sclerosis","volume":"39","author":"Miller","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ana.410360205","article-title":"The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease","volume":"36","author":"Mitsumoto","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410280103","article-title":"Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: A hypothesis","volume":"28","author":"Plaitakis","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6873_RF33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1998.6873_RF34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1476-5381.1994.tb17054.x","article-title":"The anticonvulsant and behavioural profile of L-687,414, and partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex","volume":"113","author":"Tricklebank","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6873_RF35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(93)90804-Q","article-title":"Effect of riluzole on focal cerebral ischaemia in rats","volume":"230","author":"Wahl","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6873_RF36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0006-2952(78)90525-7","article-title":"Deprenil: Loss of selectivity for inhibition of B-type MAO after repeated treatment","volume":"27","author":"Waldnierer","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/exnr.1998.6873_RF37","first-page":"239","article-title":"The role of monoamine oxidase, iron-melanin interaction and intracellular calcium in Parkinson's disease","volume":"32","author":"Youdim","year":"1990","journal-title":"J. Neurol. Transm."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448869896873X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448869896873X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T13:25:35Z","timestamp":1576589135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448869896873X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["S001448869896873X"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1998.6873","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}